Age-related decline in testosterone levels, sometimes termed late-onset hypogonadism, may manifest with decreased sexual desire, reduced muscle mass, mood disturbances, and diminished bone density.
Biochemical confirmation requires consistent measurement of low morning testosterone levels alongside clinical symptoms. Distinguishing physiological aging from pathological hypogonadism is critical.
Clinical guidelines from the Endocrine Society recommend careful evaluation before initiating testosterone replacement therapy.
Monitoring includes hematocrit levels, lipid profile, and prostate-specific antigen. Individualized treatment ensures optimal erotic balance between therapeutic benefit and safety.
Leave a Reply